Duality Advisers’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Duality Advisers’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-119,842	Closed	-$2.42M	–	733
2021 Q3	$2.42M	Buy	+119,842	New	+$3.31M	0.19%	216
2021 Q1	–	Sell	-23,995	Closed	-$529K	–	747
2020 Q4	$529K	Buy	+23,995	New	+$529K	0.04%	438

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Duality Advisers's DRNA Position: Q4 2021 in Review

Duality Advisers sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 119,842 shares — an estimated $2.42M sold.

Duality Advisers first reported a position in DRNA in Q4 2020 and held it in 2 quarters. The position peaked at $2.42M in Q3 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Duality Advisers reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Duality Advisers sold 119,842 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $2.42M.
Duality Advisers first reported a position in Dicerna Pharmaceuticals, Inc. in Q4 2020 and held it in 2 quarters.
Duality Advisers's Dicerna Pharmaceuticals, Inc. position peaked at $2.42M in Q3 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Duality Advisers's 13F filing for Q4 2021, filed 2 Feb 2022.